Theradex will attend JPM events in San Francisco, January 12-14th, 2026. Mike O’Gorman, Chief Commercial Officer, and Jeanne Schow, VP Business Development will be available to meet to discuss your asset(s) and how Theradex Oncology can support your drug development investor strategy and clinical trials. Please contact us to schedule a meeting: Contact Us | Theradex Oncology